CYPRIUM THERAPEUTICS Trademark

Trademark Overview


On Wednesday, March 15, 2017, a trademark application was filed for CYPRIUM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CYPRIUM THERAPEUTICS trademark a serial number of 87978937. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, June 10, 2024. This trademark is owned by Cyprium Therapeutics, Inc.. The CYPRIUM THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations and medicines for the treatment of Menkes disease and copper transport and metabolism diseases and disorders; Development of pharmaceutical preparations and medicines for the treatment of diseases and disorders where copper deficiency is present; Development of pharmaceutical preparations and medicines for the treatment of hematological and neurological disorders; [ Laboratory research services relating to pharmaceuticals; ] Medical research services; Pharmaceutical drug development services; Scientific research for medical purposes in the field of Menkes disease and copper transport and metabolism diseases and disorders; Scientific research for medical purposes in the field of diseases and disorders where copper deficiency is present; Scientific research for medical purposes in the field of hematological and neurological disorders [ ; Research in the field of pharmacogenetics; Conducti...
cyprium therapeutics

General Information


Serial Number87978937
Word MarkCYPRIUM THERAPEUTICS
Filing DateWednesday, March 15, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, June 10, 2024
Registration Number5624302
Registration DateTuesday, December 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Development of pharmaceutical preparations and medicines for the treatment of Menkes disease and copper transport and metabolism diseases and disorders; Development of pharmaceutical preparations and medicines for the treatment of diseases and disorders where copper deficiency is present; Development of pharmaceutical preparations and medicines for the treatment of hematological and neurological disorders; [ Laboratory research services relating to pharmaceuticals; ] Medical research services; Pharmaceutical drug development services; Scientific research for medical purposes in the field of Menkes disease and copper transport and metabolism diseases and disorders; Scientific research for medical purposes in the field of diseases and disorders where copper deficiency is present; Scientific research for medical purposes in the field of hematological and neurological disorders [ ; Research in the field of pharmacogenetics; Conducting clinical trials for others in the field of pharmaceuticals ]

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 21, 2017
Primary Code042
First Use Anywhere DateTuesday, February 28, 2017
First Use In Commerce DateTuesday, February 28, 2017

Trademark Owner History


Party NameCyprium Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameCyprium Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameCyprium Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events


Event DateEvent Description
Tuesday, June 13, 2017NON-FINAL ACTION E-MAILED
Saturday, March 18, 2017NEW APPLICATION ENTERED
Tuesday, March 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 8, 2017ASSIGNED TO EXAMINER
Tuesday, June 13, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 2, 2018NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2018NON-FINAL ACTION E-MAILED
Wednesday, January 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 3, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 24, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, September 26, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 24, 2018TEAS REQUEST TO DIVIDE RECEIVED
Monday, September 24, 2018DIVISIONAL REQUEST RECEIVED
Monday, September 24, 2018USE AMENDMENT FILED
Thursday, October 25, 2018DIVISIONAL PROCESSING COMPLETE
Thursday, October 25, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, October 30, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 31, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 10, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 10, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, June 10, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, December 4, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, December 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED